[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 932
Citations 0
Correction
September 2015

Erratum in Table

JAMA Pediatr. 2015;169(9):878. doi:10.1001/jamapediatrics.2015.2429

In the Original Investigation titled “Treatment for Preventing Tuberculosis in Children and Adolescents: A Randomized Clinical Trial of a 3-Month, 12-Dose Regimen of a Combination of Rifapentine and Isoniazid” published online January 12, 2015, and in the March 2015 print issue of JAMA Pediatrics,1 a printing error occurred in Table 2. For the Treatment completion row, the difference (95% CI), which read “−7.2 (−2.0 to −2.5),” should be replaced with “−7.2 (−12.0 to −2.5).” This article was corrected online.

References
1.
Villarino  ME, Scott  NA, Weis  SE,  et al; International Maternal Pediatric and Adolescents AIDS Clinical Trials Group (IMPAACT); Tuberculosis Trials Consortium (TBTC).  Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.  JAMA Pediatr. 2015;169(3):247-255.PubMedArticle
×